Back to Back Issues Page
Latest Development for Argus II
November 29, 2016
Hello

Latest Development for Argus II

Five patients with the severe form of dry age related macular degeneration have received the Argus II implant at the Manchester Royal Hospital in the United Kingdom. This group of patients have had their implant for 5-15 months and are now being followed-up.

Paulo E. Stanga, MD, from the Manchester Royal Eye Hospital states, "One of the biggest challenges for the five patients is balancing their residual peripheral vision with the central visual function which the device provides."

Bypasses Photoreceptor Cells

The Argus II technology works by bypassing damaged photoreceptor cells, rods and cones that are responsible for converting light, so that the brain can perceive images via the optic nerve. The system consists of:

1. Implanted electrodes on the retina in a single eye
2. An external miniature video camera
3. A video processing unit
4. Eyeglasses that include a transmitter

Listen to Dr. Stanga as he provides us with the latest update on Argus II and find out how this electronic retinal prosthesis works and how it's impacting lives.

Latest Update on Argus II with Paulo E. Stanga, MD, from the Manchester Royal Eye Hospital  

Leslie Degner, RN, BSN

Better Health for Better Vision

www.WebRN-MacularDegeneration.com

Back to Back Issues Page